Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

India flag India · Delayed Price · Currency is INR
449.30
+6.05 (1.36%)
Mar 9, 2026, 3:29 PM IST
7.49%
Market Cap 142.34B
Revenue (ttm) 19.76B
Net Income (ttm) 1.26B
Shares Out 316.81M
EPS (ttm) 3.96
PE Ratio 113.33
Forward PE 84.94
Dividend n/a
Ex-Dividend Date n/a
Volume 82,309
Average Volume 131,640
Open 435.00
Previous Close 443.25
Day's Range 430.00 - 452.10
52-Week Range 327.00 - 568.00
Beta n/a
RSI 43.06
Earnings Date May 26, 2026

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr... [Read more]

Sector Healthcare
Founded 2010
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol AGARWALEYE
Full Company Profile

Financial Performance

In fiscal year 2025, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.

Financial Statements

News

There is no news available yet.